Table 2. Tissue types of the tiles used for different prediction targets.
| Prediction categories | Prediction targets | Tissue types of tiles sampled |
|---|---|---|
| Clinical pathological features | T1 | Tumor |
| T2–3 | Tumor | |
| N0 | Tumor | |
| N1–3 | Tumor | |
| Grade I | Tumor | |
| Grade II | Tumor | |
| Grade III | Tumor | |
| Low Ki67 | Tumor | |
| High Ki67 | Tumor | |
| Somatic mutations | PIK3CA | Tumor |
| TP53 | Tumor | |
| GATA3 | Tumor | |
| MAP3K1 | Tumor | |
| KMT2C | Tumor | |
| AKT1 | Tumor | |
| PTEN | Tumor | |
| FAT3 | Tumor | |
| SF3B1 | Tumor | |
| Gene set enrichment analysis scores | Angiogenesis | Tumor |
| DNA repair | Tumor | |
| Estrogen response early | Tumor | |
| G2-M checkpoint | Tumor | |
| IFN-γ response | Tumor | |
| PI3K/AKT/mTOR signaling | Tumor | |
| Immunotherapy biomarkers | iTILs | Tumor |
| sTILs | Stroma and immune infiltrates | |
| CD8A mRNA | Stroma and immune infiltrates | |
| PDCD1 mRNA | Stroma and immune infiltrates | |
| CD274 mRNA | Tumor, stroma and immune infiltrates | |
| Prognosis | OS | All five tissue types |
| DFS | All five tissue types |
iTILs, intratumoral tumor-infiltrating lymphocytes; sTILs, stromal tumor-infiltrating lymphocytes; OS, overall survival; DFS, disease-free survival.